Larixol

Modify Date: 2024-01-29 18:01:12

Larixol Structure
Larixol structure
Common Name Larixol
CAS Number 1438-66-0 Molecular Weight 390.55600
Density 1.01g/cm3 Boiling Point 440.5ºC at 760mmHg
Molecular Formula C24H38O4 Melting Point N/A
MSDS N/A Flash Point 205.3ºC

 Use of Larixol


Larixol is an fMLP inhibitor and also inhibits Src kinase, ERK1/2, p38 and AKT phosphorylation signals in immune regulation. Larixol can interfere with the interaction between the βγ subunit of the fMLP receptor Gi protein and its downstream molecules, thereby inhibiting fMLP-induced respiratory burst. Larixol inhibits fMLP (0.1 μM)-induced superoxide anion production (IC50: 1.98 μM), cathepsin G release (IC50: 2.76 μM), and chemotaxis. Larixol improves neutrophil hyperactivation and reduces inflammation or tissue damage. A series of Larixol derivatives were found to have inhibitory effects on FSGS-related TRPC6 functional mutants[1][2].

 Names

Name [4-(3-acetyloxy-3-methylpent-4-enyl)-4a,8,8-trimethyl-3-methylidene-2,4,5,6,7,8a-hexahydro-1H-naphthalen-1-yl] acetate
Synonym More Synonyms

 Larixol Biological Activity

Description Larixol is an fMLP inhibitor and also inhibits Src kinase, ERK1/2, p38 and AKT phosphorylation signals in immune regulation. Larixol can interfere with the interaction between the βγ subunit of the fMLP receptor Gi protein and its downstream molecules, thereby inhibiting fMLP-induced respiratory burst. Larixol inhibits fMLP (0.1 μM)-induced superoxide anion production (IC50: 1.98 μM), cathepsin G release (IC50: 2.76 μM), and chemotaxis. Larixol improves neutrophil hyperactivation and reduces inflammation or tissue damage. A series of Larixol derivatives were found to have inhibitory effects on FSGS-related TRPC6 functional mutants[1][2].
Related Catalog
Target

(+)-Larixol[1]

References

[1]. Liao HR, et al. Larixol inhibits fMLP-induced superoxide anion production and chemotaxis by targeting the βγ subunit of Gi-protein of fMLP receptor in human neutrophils. Biochem Pharmacol. 2022 Jul;201:115091.  

[2]. Urban N, et al. Pharmacological inhibition of focal segmental glomerulosclerosis-related, gain of function mutants of TRPC6 channels by semi-synthetic derivatives of larixol. Br J Pharmacol. 2017 Nov;174(22):4099-4122.  

 Chemical & Physical Properties

Density 1.01g/cm3
Boiling Point 440.5ºC at 760mmHg
Molecular Formula C24H38O4
Molecular Weight 390.55600
Flash Point 205.3ºC
Exact Mass 390.27700
PSA 52.60000
LogP 5.61480
Vapour Pressure 5.88E-08mmHg at 25°C
Index of Refraction 1.495

 Synonyms

larixol acetate
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.